Search

Niloofar Rahmani

Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1625, 1691, 1621
Total Applications
2303
Issued Applications
1739
Pending Applications
128
Abandoned Applications
466

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4746215 [patent_doc_number] => 20080090817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase' [patent_app_type] => utility [patent_app_number] => 11/951097 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52549 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090817.pdf [firstpage_image] =>[orig_patent_app_number] => 11951097 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/951097
Bridged N-cyclic sulfonamido inhibitors of gamma secretase Dec 4, 2007 Issued
Array ( [id] => 6007971 [patent_doc_number] => 20110060002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'CONGLOMERATES OF TENATOPRAZOLE POTASSIUM SALTS' [patent_app_type] => utility [patent_app_number] => 12/448055 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6644 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20110060002.pdf [firstpage_image] =>[orig_patent_app_number] => 12448055 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/448055
Conglomerates of tenatoprazole potassium salts Dec 2, 2007 Issued
Array ( [id] => 6257763 [patent_doc_number] => 20100029710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIES' [patent_app_type] => utility [patent_app_number] => 12/518472 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 53985 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029710.pdf [firstpage_image] =>[orig_patent_app_number] => 12518472 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/518472
COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIES Dec 2, 2007 Abandoned
Array ( [id] => 8784750 [patent_doc_number] => 08431593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-30 [patent_title] => 'Heteroaryl amide derivatives' [patent_app_type] => utility [patent_app_number] => 12/516480 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57803 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12516480 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/516480
Heteroaryl amide derivatives Nov 26, 2007 Issued
Array ( [id] => 6455707 [patent_doc_number] => 20100105723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => '5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/521133 [patent_app_country] => US [patent_app_date] => 2007-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5747 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105723.pdf [firstpage_image] =>[orig_patent_app_number] => 12521133 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/521133
5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS Nov 22, 2007 Abandoned
Array ( [id] => 5272270 [patent_doc_number] => 20090076046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Compounds modulating c-fms and/or c-kit activity and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/986667 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 144145 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076046.pdf [firstpage_image] =>[orig_patent_app_number] => 11986667 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/986667
Compounds modulating c-fms and/or c-kit activity and uses therefor Nov 20, 2007 Issued
Array ( [id] => 123569 [patent_doc_number] => 07705152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Alcohol oxidation catalyst and its preparation process' [patent_app_type] => utility [patent_app_number] => 11/943836 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 7071 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705152.pdf [firstpage_image] =>[orig_patent_app_number] => 11943836 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/943836
Alcohol oxidation catalyst and its preparation process Nov 20, 2007 Issued
Array ( [id] => 53319 [patent_doc_number] => 07772239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/986212 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23184 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772239.pdf [firstpage_image] =>[orig_patent_app_number] => 11986212 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/986212
Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists Nov 19, 2007 Issued
Array ( [id] => 6258545 [patent_doc_number] => 20100029944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Process for the Synthesis of Solifenacin' [patent_app_type] => utility [patent_app_number] => 12/515689 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4497 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029944.pdf [firstpage_image] =>[orig_patent_app_number] => 12515689 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/515689
Process for the Synthesis of Solifenacin Nov 19, 2007 Abandoned
Array ( [id] => 247124 [patent_doc_number] => 07585876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands' [patent_app_type] => utility [patent_app_number] => 11/941479 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14866 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585876.pdf [firstpage_image] =>[orig_patent_app_number] => 11941479 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/941479
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands Nov 15, 2007 Issued
Array ( [id] => 4753189 [patent_doc_number] => 20080161264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'TRIAZOLYL TROPANE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/941925 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11694 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161264.pdf [firstpage_image] =>[orig_patent_app_number] => 11941925 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/941925
Triazolyl tropane derivatives Nov 15, 2007 Issued
Array ( [id] => 102746 [patent_doc_number] => 07723355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => '7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods' [patent_app_type] => utility [patent_app_number] => 11/941181 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19693 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723355.pdf [firstpage_image] =>[orig_patent_app_number] => 11941181 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/941181
7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods Nov 15, 2007 Issued
Array ( [id] => 4765682 [patent_doc_number] => 20080176894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Novel aminopyridine-derivatives' [patent_app_type] => utility [patent_app_number] => 11/984364 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23200 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176894.pdf [firstpage_image] =>[orig_patent_app_number] => 11984364 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/984364
Aminopyridine-derivatives Nov 15, 2007 Issued
Array ( [id] => 159433 [patent_doc_number] => 07674795 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Fluorene derivatives, composition containing said derivatives and the use thereof' [patent_app_type] => utility [patent_app_number] => 11/939735 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102146 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674795.pdf [firstpage_image] =>[orig_patent_app_number] => 11939735 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/939735
Fluorene derivatives, composition containing said derivatives and the use thereof Nov 13, 2007 Issued
Array ( [id] => 4887905 [patent_doc_number] => 20080262237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'BLACK PIGMENT, BLACK PIGMENT DISPERSION AND BLACK RESIN COMPOSITION COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/938990 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8557 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262237.pdf [firstpage_image] =>[orig_patent_app_number] => 11938990 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/938990
Black pigment, black pigment dispersion and black resin composition comprising the same Nov 12, 2007 Issued
Array ( [id] => 8257714 [patent_doc_number] => 08207193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/514509 [patent_app_country] => US [patent_app_date] => 2007-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25041 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12514509 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/514509
Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists Nov 12, 2007 Issued
Array ( [id] => 6257371 [patent_doc_number] => 20100029643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/514247 [patent_app_country] => US [patent_app_date] => 2007-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53507 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029643.pdf [firstpage_image] =>[orig_patent_app_number] => 12514247 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/514247
HETEROCYCLYC SULFONAMIDES HAVING EDG-1 ANTAGONISTIC ACTIVITY Nov 7, 2007 Abandoned
Array ( [id] => 8082087 [patent_doc_number] => 08148361 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/513928 [patent_app_country] => US [patent_app_date] => 2007-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12948 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148361.pdf [firstpage_image] =>[orig_patent_app_number] => 12513928 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/513928
Kinase inhibitors Nov 6, 2007 Issued
Array ( [id] => 4873733 [patent_doc_number] => 20080200467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'SOLUBLE EPOXIDE HYDROLASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/934698 [patent_app_country] => US [patent_app_date] => 2007-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36023 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200467.pdf [firstpage_image] =>[orig_patent_app_number] => 11934698 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/934698
SOLUBLE EPOXIDE HYDROLASE INHIBITORS Nov 1, 2007 Abandoned
Array ( [id] => 4965830 [patent_doc_number] => 20080108650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Phosphodiesterase 10A inhibitor' [patent_app_type] => utility [patent_app_number] => 11/980526 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2084 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108650.pdf [firstpage_image] =>[orig_patent_app_number] => 11980526 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/980526
Phosphodiesterase 10A inhibitor Oct 30, 2007 Issued
Menu